Skip to content
MedsAcross

Medicine

Ibuprofen 800 mg tablet

Ibuprofen · Oral
Available on requestPrescription onlyUS FDAGeneric name

Ibuprofen 800 mg tablet is a generic prescription medicine for oral use, made by 47 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at room temperature. Avoid excessive heat 40°C (104°F).

Key facts

Active ingredient (INN)
Ibuprofen
Brand
Sold under the generic name
Strength
800 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 30 tablets and 454 more
Manufacturers
Ascend LaboratoriesIndiaGranules IndiaIndiaTime Cap LaboratoriesIndiaAurobindo PharmaIndiaMarksans PharmaIndiaStrides PharmaIndiaAmneal Pharmaceuticals of New York47 labelers on the register
Origin register
US FDA, United States
Storage
Store at room temperature. Avoid excessive heat 40°C (104°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C01EB16 Ibuprofen
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
20 November 2008
Identifiers
RxCUI 197807, 197805, 197806DailyMed set ID 31e6ac7a-fa3e-4dd4-e063-6294a90a29af, c1733fdb-5eed-2094-e053-2995a90a6c8e, 0cb73c19-a7cb-4ad9-9aa5-c24afb80d6d8 +37NDC 71610-892, 71921-182, 72789-364 +37Application ANDA075682, ANDA071268, ANDA091625 +8

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 47 labelers. The register lists 457 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 tablet, film coated in 1 bottle67877-321-01Ascend LaboratoriesIndia21 December 2015
500 tablet, film coated in 1 bottle67877-321-05Ascend LaboratoriesIndia21 December 2015
30 tablet, film coated in 1 bottle67877-321-30Ascend LaboratoriesIndia21 December 2015
50 tablet, film coated in 1 bottle67877-321-50Ascend LaboratoriesIndia21 December 2015
100 tablet, film coated in 1 bottle67877-739-01Ascend LaboratoriesIndia15 September 2026
500 tablet, film coated in 1 bottle67877-739-05Ascend LaboratoriesIndia15 September 2026
30 tablet, film coated in 1 bottle67877-739-30Ascend LaboratoriesIndia15 September 2026
1 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack67877-739-33Ascend LaboratoriesIndia15 September 2026
50 tablet, film coated in 1 bottle67877-739-50Ascend LaboratoriesIndia15 September 2026
60 tablet, film coated in 1 bottle67877-739-60Ascend LaboratoriesIndia15 September 2026
90 tablet, film coated in 1 bottle67877-739-90Ascend LaboratoriesIndia15 September 2026
50 tablet, film coated in 1 bottle62207-356-42Granules IndiaIndia21 September 2015
100 tablet, film coated in 1 bottle62207-356-43Granules IndiaIndia21 September 2015
500 tablet, film coated in 1 bottle62207-356-47Granules IndiaIndia21 September 2015
1000 tablet, film coated in 1 bottle62207-356-49Granules IndiaIndia21 September 2015
30 tablet, film coated in 1 bottle62207-356-54Granules IndiaIndia21 September 2015
100 tablet, film coated in 1 bottle70010-068-01Granules IndiaIndia18 February 2026
30 tablet, film coated in 1 bottle70010-068-03Granules IndiaIndia18 February 2026
500 tablet, film coated in 1 bottle70010-068-05Granules IndiaIndia18 February 2026
1000 tablet, film coated in 1 bottle70010-068-10Granules IndiaIndia18 February 2026
50 tablet, film coated in 1 bottle70010-068-50Granules IndiaIndia18 February 2026
9 blister pack in 1 carton / 14 tablet, film coated in 1 blister pack70010-068-82Granules IndiaIndia18 February 2026
100 tablet in 1 bottle59651-362-01Aurobindo PharmaIndia8 May 2020
500 tablet in 1 bottle59651-362-05Aurobindo PharmaIndia8 May 2020
30 tablet in 1 bottle25000-123-03Marksans PharmaIndia28 February 2011
500 tablet in 1 bottle25000-123-12Marksans PharmaIndia28 February 2011
100 tablet, film coated in 1 bottle64380-807-06Strides PharmaIndia24 August 2018
500 tablet, film coated in 1 bottle64380-807-07Strides PharmaIndia24 August 2018
100 tablet, film coated in 1 bottle49483-604-01Time Cap LaboratoriesIndia30 December 2015
30 tablet, film coated in 1 bottle49483-604-03Time Cap LaboratoriesIndia30 December 2015
50 tablet, film coated in 1 bottle49483-604-05Time Cap LaboratoriesIndia30 December 2015
500 tablet, film coated in 1 bottle49483-604-50Time Cap LaboratoriesIndia30 December 2015
100 tablet in 1 bottle53746-137-01Amneal Pharmaceuticals of New York5 January 2009
500 tablet in 1 bottle53746-137-05Amneal Pharmaceuticals of New York5 January 2009
30 tablet in 1 bottle53746-137-30Amneal Pharmaceuticals of New York5 January 2009
50 tablet in 1 bottle53746-137-50Amneal Pharmaceuticals of New York5 January 2009
60 tablet in 1 bottle53746-137-60Amneal Pharmaceuticals of New York5 January 2009
90 tablet in 1 bottle53746-137-90Amneal Pharmaceuticals of New York5 January 2009
100 tablet in 1 bottle53746-466-01Amneal Pharmaceuticals of New York23 November 2009
500 tablet in 1 bottle53746-466-05Amneal Pharmaceuticals of New York23 November 2009

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 19 September 1974Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Ibuprofen 800 mg tablet.

Compare 1

Other strengths and forms of Ibuprofen

Clinical summary

Ibuprofen is a nonsteroidal anti-inflammatory drug indicated to close a clinically significant patent ductus arteriosus (PDA) in premature infants weighing between 500 and 1500 g,, among other approved uses. MedsAcross supplies Ibuprofen for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ibuprofen

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ibuprofen 800 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.